A detailed history of Two Sigma Investments, LP transactions in 89bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 368,688 shares of ETNB stock, worth $2.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
368,688
Previous 533,717 30.92%
Holding current value
$2.28 Million
Previous $4.28 Million 36.19%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.36 - $9.66 $1.21 Million - $1.59 Million
-165,029 Reduced 30.92%
368,688 $2.73 Million
Q2 2024

Aug 14, 2024

BUY
$7.31 - $10.9 $2.1 Million - $3.14 Million
287,617 Added 116.87%
533,717 $4.28 Million
Q1 2024

May 15, 2024

BUY
$8.13 - $13.77 $953,990 - $1.62 Million
117,342 Added 91.13%
246,100 $2.86 Million
Q4 2023

Feb 14, 2024

SELL
$6.66 - $16.03 $552,906 - $1.33 Million
-83,019 Reduced 39.2%
128,758 $1.44 Million
Q3 2023

Nov 14, 2023

SELL
$15.06 - $19.41 $6.34 Million - $8.17 Million
-420,908 Reduced 66.53%
211,777 $3.27 Million
Q2 2023

Aug 14, 2023

SELL
$14.15 - $22.03 $3.33 Million - $5.18 Million
-235,276 Reduced 27.11%
632,685 $12 Million
Q1 2023

May 15, 2023

BUY
$10.48 - $16.94 $1.61 Million - $2.61 Million
153,796 Added 21.54%
867,961 $13.2 Million
Q4 2022

Feb 14, 2023

BUY
$5.52 - $12.73 $1.24 Million - $2.86 Million
224,641 Added 45.89%
714,165 $9.09 Million
Q3 2022

Nov 14, 2022

BUY
$3.02 - $7.0 $1 Million - $2.33 Million
332,610 Added 211.97%
489,524 $2.83 Million
Q2 2022

Aug 15, 2022

SELL
$2.09 - $4.02 $132,723 - $255,286
-63,504 Reduced 28.81%
156,914 $505,000
Q1 2022

May 16, 2022

BUY
$3.45 - $14.99 $561,532 - $2.44 Million
162,763 Added 282.31%
220,418 $831,000
Q4 2021

Feb 14, 2022

SELL
$11.15 - $19.66 $216,321 - $381,423
-19,401 Reduced 25.18%
57,655 $754,000
Q3 2021

Nov 15, 2021

SELL
$14.91 - $21.31 $361,224 - $516,277
-24,227 Reduced 23.92%
77,056 $1.51 Million
Q2 2021

Aug 16, 2021

SELL
$17.42 - $28.0 $991,076 - $1.59 Million
-56,893 Reduced 35.97%
101,283 $1.89 Million
Q1 2021

May 17, 2021

SELL
$20.22 - $26.73 $206,345 - $272,779
-10,205 Reduced 6.06%
158,176 $3.75 Million
Q4 2020

Feb 16, 2021

BUY
$23.16 - $28.08 $2.59 Million - $3.14 Million
111,821 Added 197.7%
168,381 $4.1 Million
Q3 2020

Nov 16, 2020

BUY
$24.34 - $38.82 $1.38 Million - $2.2 Million
56,560 New
56,560 $1.45 Million

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $287M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.